Clinical trial
Early Detection of Myocardial Ischaemia in Suspected Acute Coronary Syndromes by Apo J-Glyc as a Novel Pathologically-based Ischaemia Biomarker
NCT04119882 is registered in ClinicalTrials.gov with Glycardial Diagnostics S.L. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Detection of Myocardial Ischaemia in Suspected Acute Coronary Syndromes by Apo J-Glyc as a Novel Pathologically-based Ischaemia Biomarker
- Lead sponsor
- Glycardial Diagnostics S.L.
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 20, 2019
- Completion date
- September 20, 2021
- Enrollment
- 404 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.